Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

tezacitabine MeSH Supplementary Concept Data 2026


MeSH Supplementary
tezacitabine
Unique ID
C086432
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C086432
Entry Term(s)
2'-deoxy-2'-(fluoromethylene)cytidine
MDL 101,731
MDL 101731
MDL-101,731
MDL-101731
Pharm Action
Antineoplastic Agents
Enzyme Inhibitors
Radiation-Sensitizing Agents
Registry Numbers
UCC4EQS7WL
Related Numbers
130306-02-4
CAS Type 1 Name
Cytidine, 2'-deoxy-2'-(fluoromethylene)-, (2E)-
Heading Mapped to
Deoxycytidine / analogs & derivatives
Frequency
31
Note
structure given in first source
Source
Cancer Res 1994 Mar 15;54(6):1485-90
Indexing Information
Ribonucleoside Diphosphate Reductase
Date Introduced
1994/04/22
Last Updated
2012/11/05
tezacitabine Preferred
MDL 101731 Narrower
page delivered in 0.006s